ConductScience.org, home

Paper3697995

Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.

D'Incalci M and 7 others. Cancer Res, 1986. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function. Papers, record 3697995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3697995

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.
PubMed
Journal
Cancer Res
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
4.79
iCite
Revised in PubMed
2022-03-11
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Incalci MM
2Rossi CC
3Zucchetti MM
4Urso RR
5Cavalli FF
6Mangioni CC
7Willems YY
8Sessa CC

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EtoposideMajor topic
Kidney DiseasesMajor topic
Liver DiseasesMajor topic
PodophyllotoxinMajor topic
Adult
Aged
Female
Humans
Male
Metabolic Clearance Rate
Middle Aged

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
32676789Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.Pharm Res2020https://conductscience.org/library/papers/32676789PubMed
30947665Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure.Curr Drug Metab2019https://conductscience.org/library/papers/30947665PubMed
30328531Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer.Int J Clin Oncol2019https://conductscience.org/library/papers/30328531PubMed
30261554
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
Br J Clin Pharmacol2019https://conductscience.org/library/papers/30261554PubMed
29209521Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).ESMO Open2017https://conductscience.org/library/papers/29209521PubMed
23968328Acute myeloid leukemia in a 38-year-old hemodialyzed patient with von Hippel-Lindau disease.Hered Cancer Clin Pract2013https://conductscience.org/library/papers/23968328PubMed
21298312Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.Clin Exp Nephrol2011https://conductscience.org/library/papers/21298312PubMed
16752933Dose adaptation of antineoplastic drugs in patients with liver disease.Drug Saf2006https://conductscience.org/library/papers/16752933PubMed
16524321Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.Drug Saf2006https://conductscience.org/library/papers/16524321PubMed
15170366Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.Clin Pharmacokinet2004https://conductscience.org/library/papers/15170366PubMed
15139794Pharmacokinetic optimisation of treatment with oral etoposide.Clin Pharmacokinet2004https://conductscience.org/library/papers/15139794PubMed
12448655Phase I escalation of gemcitabine combined with protracted oral etoposide in gynecologic malignancies: A Gynecologic Oncology Group study.Invest New Drugs2002https://conductscience.org/library/papers/12448655PubMed
11736859Population pharmacokinetics and pharmacodynamics of oral etoposide.Br J Clin Pharmacol2001https://conductscience.org/library/papers/11736859PubMed
8611379Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.Br J Cancer1996https://conductscience.org/library/papers/8611379PubMed
8431968Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8431968PubMed
8070032Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8070032PubMed
7961107In vitro and in vivo effects of cisplatin and etoposide in combination on small cell lung cancer cell lines.Jpn J Cancer Res1994https://conductscience.org/library/papers/7961107PubMed
7497587Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497587PubMed
3555940Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet1987https://conductscience.org/library/papers/3555940PubMed
3047665Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.Pharm Weekbl Sci1988https://conductscience.org/library/papers/3047665PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3697995

GET https://conductscience.org/api/papers/v1/3697995/cited_by?page=2